United States (US) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
The US biotechnology market recorded revenues of $361.6 billion in 2023, representing a compound annual growth rate (CAGR) of 12.7% between 2018 and 2023.
The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $236.2 billion, equivalent to 65.3% of the market's overall value.
The US biotechnology market experienced a contraction in 2023 due to challenges and a record number of biotech bankruptcies. As reported until October 2023, 28 biotech firms have declared bankruptcy, a significant increase compared to previous years. Despite a global uptick in biotech funding reaching $75 billion, this represents only 50% of the peak during the pandemic.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts

Reasons to Buy

What was the size of the United States biotechnology market by value in 2023?
What will be the size of the United States biotechnology market in 2028?
What factors are affecting the strength of competition in the United States biotechnology market?
How has the market performed over the last five years?
Who are the top competitors in the United States's biotechnology market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?

8 Company Profiles

8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related Research
10.4. About the Publisher

List of Tables

Table 1: United States biotechnology industry value: $ million, 2018-23
Table 2: United States biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: United States biotechnology industry category segmentation: $ million, 2018-2023
Table 4: United States biotechnology industry geography segmentation: $ million, 2023
Table 5: United States biotechnology industry value forecast: $ million, 2023-28
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: AbbVie Inc.: key facts
Table 11: AbbVie Inc.: Annual Financial Ratios
Table 12: AbbVie Inc.: Key Employees
Table 13: AbbVie Inc.: Key Employees Continued
Table 14: Amgen, Inc.: key facts
Table 15: Amgen, Inc.: Annual Financial Ratios
Table 16: Amgen, Inc.: Key Employees
Table 17: Amgen, Inc.: Key Employees Continued
Table 18: Biogen, Inc.: key facts
Table 19: Biogen, Inc.: Annual Financial Ratios
Table 20: Biogen, Inc.: Key Employees
Table 21: Biogen, Inc.: Key Employees Continued
Table 22: United States size of population (million), 2019-23
Table 23: United States gdp (constant 2005 prices, $ billion), 2019-23
Table 24: United States gdp (current prices, $ billion), 2019-23
Table 25: United States inflation, 2019-23
Table 26: United States consumer price index (absolute), 2019-23
Table 27: United States exchange rate, 2019-23

List of Figures

Figure 1: United States biotechnology industry value: $ million, 2018-23
Figure 2: United States biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: United States biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Johnson & Johnson
AbbVie Inc.
Amgen, Inc.
Biogen, Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€320EUR$350USD£271GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€479EUR$525USD£407GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€639EUR$700USD£542GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Biotechnology Market Report by Product Type, Technology, Application, and Region 2024-2032

Biotechnology for the Non-Biotechnologist Training Course (November 10-14, 2025)

Biotechnology Market in the US 2025-2029

Biotech Market 2025-2029

Antibody Drugs: Technologies and Global Markets